Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels

2018 ◽  
Vol 70 (7) ◽  
pp. 919-928 ◽  
Author(s):  
Anna Rita Bilia ◽  
Maria Camilla Bergonzi ◽  
Benedetta Isacchi ◽  
Emiliano Antiga ◽  
Marzia Caproni
Keyword(s):  
Serum Cholesterol ◽  
Severe Psoriasis ◽  
Therapeutic Effectiveness ◽  
Curcumin Nanoparticles ◽  
Cholesterol Levels ◽  
Control Serum ◽  
And Control

EFFECTS OF EXERCISE AND A CHOLESTEROL-FREE DIET ON HUMAN SERUM LIPIDS

1966 ◽  
Vol 44 (4) ◽  
pp. 575-580 ◽  
Author(s):  
R. C. Goode ◽  
J. B. Firstbrook ◽  
R. J. Shephard
Keyword(s):  
Serum Cholesterol ◽  
Serum Triglycerides ◽  
Animal Fats ◽  
Cholesterol Levels ◽  
Daily Energy ◽  
Exercise Period ◽  
Small Rise ◽  
And Control ◽  
Caloric Balance ◽  
Male Subjects

Six male subjects were maintained on a diet free of all animal fats for 54 days; carbohydrate intake was increased to maintain an approximate caloric balance. Serum cholesterol decreased progressively to a low plateau over the first 3 weeks, and thereafter showed a small rise, suggesting increased synthesis. Treadmill exercise sufficient to increase daily energy expenditure by a sixth was carried out for 14 days during the phase of increased synthesis. Serum cholesterol levels did not differ significantly between exercised and control subjects, but serum triglycerides decreased significantly (P < 0.05) over the exercise period.

scholarly journals Obesity Does Not Interfere with the Cholesterol-Lowering Effect of Plant Stanol Ester Consumption (as Part of a Heart-Healthy Diet)

2021 ◽  
Vol 8 (4) ◽  
pp. 36
Author(s):  
Piia Simonen ◽  
Elisa Arte ◽  
Helena Gylling
Keyword(s):  
Serum Cholesterol ◽  
Cholesterol Metabolism ◽  
Dietary Cholesterol ◽  
Cholesterol Absorption ◽  
Normal Weight ◽  
Plant Stanol Ester ◽  
Cholesterol Levels ◽  
Plant Stanol ◽  
Control Serum ◽  
Stanol Ester

Dietary modifications including plant stanol ester consumption are recommended measures to control serum and low-density lipoprotein (LDL)-cholesterol concentrations, but obesity can affect their responses. We investigated whether body mass index (BMI) affects serum cholesterol levels during plant stanol (mainly sitostanol) ester consumption. This ad hoc analysis was based on earlier results of a cross-over, randomized controlled trial of postmenopausal women consuming rapeseed oil-based margarine without or with plant stanol ester (3 g plant stanols/day) for seven weeks. We classified the subjects as normal-weight (BMI ≤ 25 kg/m2, n = 9, mean 22.6 kg/m2) or overweight/obese (BMI > 25 kg/m2, n = 11, mean 28.4 kg/m2), and recalculated the results, focusing on cholesterol absorption, cholesterol synthesis, and fecal steroid outputs. Serum cholesterol levels were similar in the groups during the control diet. Plant stanol ester reduced serum cholesterol by 0.63 ± 0.19 mmol/L (11%) in normal-weight and by 0.75 ± 0.13 mmol/L (12%) in overweight/obese subjects (p < 0.05 for both), and cholesterol absorption was reduced in both groups. However, relative and dietary cholesterol absorption were more effectively reduced in normal-weight subjects. In conclusion, overweight/obesity did not interfere with the serum cholesterol response to plant stanol ester consumption despite substantial differences in cholesterol metabolism between the groups.

Fat Metabolism in Experimental Obesities

1956 ◽  
Vol 187 (2) ◽  
pp. 365-368 ◽  
Author(s):  
Claire Zomzely ◽  
J. Mayer
Keyword(s):  
Fatty Acids ◽  
Serum Cholesterol ◽  
Cholesterol Content ◽  
Liver Cholesterol ◽  
Tumor Bearing ◽  
Cholesterol Levels ◽  
Body Weights ◽  
And Control ◽  
Normal Controls

In vivo incorporation of acetate-1-C14 into fatty acids and cholesterol by carcass and liver was determined 30 minutes after injection of the labeled acetate in mice grafted with adrenocorticotropin-secreting tumors. Serum cholesterol levels were also determined. Lipogenesis is elevated under fed and fasted conditions in mice bearing adrenocorticotropin-secreting tumors as compared with normal controls or tumor-bearing adrenalectomized mice. Cholesterologenesis was not significantly different in fed tumor-bearing and control mice. When fasted, however, the tumor-bearing mice exhibited greater incorporation of C14 than that of their controls. Fasting did not decrease cholesterologenesis in the former group. Serum cholesterol levels of the adrenocorticotropic mice were found to be twice as high as those of controls. In addition, the amounts of carcass and liver fatty acids were three times as great for the ACTH mice as compared with controls, although their body weights did not differ significantly. Carcass and liver cholesterol content of adrenocorticotropic mice was also elevated. The results of this experiment indicate that mice bearing adrenocorticotropin-secreting tumors exhibit a ‘metabolic’ type of obesity.

scholarly journals High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?

1998 ◽  
pp. 141-145 ◽  
Author(s):  
G Michalopoulou ◽  
M Alevizaki ◽  
G Piperingos ◽  
D Mitsibounas ◽  
E Mantzos ◽  
...  
Keyword(s):  
Total Cholesterol ◽  
Serum Cholesterol ◽  
Subclinical Hypothyroidism ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
High Serum ◽  
High Serum Cholesterol ◽  
Cholesterol Levels ◽  
Group D ◽  
Tsh Levels

OBJECTIVE: The association between established hypothyroidism and high cholesterol levels is well known. The aim of the present study was to investigate the effect of thyroxine (T4) administration on cholesterol levels in hypercholesterolemic subjects with TSH levels within the normal range ('high-normal' TSH compared with 'low-normal' TSH). DESIGN AND METHODS: We determined TSH levels in 110 consecutive patients referred for hypercholesterolemia (serum cholesterol >7.5 mmol/l). Those with 'high-normal' TSH (2.0-4.0 microU/ml) as well as those with 'low-normal' TSH (0.40-1.99 microU/ml) were randomly assigned to receive either 25 or 50 microg T4 daily for two months. Thus, groups A and B (low-normal TSH) received 25 and 50 microg T4 respectively and groups C and D (high-normal TSH) received 25 and 50 microg T4 respectively. Serum T4, tri-iodothyronine (T3), TSH, free thyroxine index, resin T3 uptake and thyroid autoantibodies (ThAab) as well as total cholesterol, high and low density lipoprotein cholesterol (HDL, LDL), and triglycerides were determined before and at the end of the two-month treatment period. RESULTS: TSH levels were reduced in all groups. The most striking effect was observed in group D (TSH levels before: 2.77+/-0.55, after: 1.41+/-0.85 microU/ml, P < 0.01). Subjects in groups C and D had a higher probability of having positive ThAabs. A significant reduction in total cholesterol (P < 0.01) and LDL (P < 0.01) was observed after treatment only in group D. In those subjects in group D who were ThAab negative, there was no significant effect of thyroxine on cholesterol levels. CONCLUSIONS: Subjects with high-normal TSH levels combined with ThAabs may, in fact, have subclinical hypothyroidism presenting with elevated cholesterol levels. It is possible that these patients might benefit from thyroxine administration.

Longitudinal associations between serum cholesterol levels and suicidal ideation in an older Korean population

2014 ◽  
Vol 152-154 ◽  
pp. 517-521 ◽  
Author(s):  
Jae-Min Kim ◽  
Robert Stewart ◽  
Hee-Ju Kang ◽  
Bo-ok Jeong ◽  
Seon-Young Kim ◽  
...  
Keyword(s):  
Suicidal Ideation ◽  
Serum Cholesterol ◽  
Korean Population ◽  
Cholesterol Levels ◽  
Longitudinal Associations

Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels

10.1038/4027 ◽  
1998 ◽  
Vol 4 (12) ◽  
pp. 1434-1437 ◽  
Author(s):  
Matti K. Karvonen ◽  
Ullamari Pesonen ◽  
Markku Koulu ◽  
Leo Niskanen ◽  
Markku Laakso ◽  
...  
Keyword(s):  
Neuropeptide Y ◽  
Serum Cholesterol ◽  
Signal Peptide ◽  
Ldl Cholesterol ◽  
High Serum ◽  
High Serum Cholesterol ◽  
Cholesterol Levels
Sign in / Sign up

Export Citation Format

Share Document